z-logo
open-access-imgOpen Access
SARS, MERS and COVID-19: clinical manifestations and organ-system complications: a mini review
Author(s) -
Jad Gerges Harb,
Hussein A Noureldine,
Georges Chedid,
Mariam Nour Eldine,
Dany Abou Abdallah,
Nancy Falco Chedid,
Wared NourEldine
Publication year - 2020
Publication title -
pathogens and disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.983
H-Index - 105
ISSN - 2049-632X
DOI - 10.1093/femspd/ftaa033
Subject(s) - middle east respiratory syndrome , middle east respiratory syndrome coronavirus , medicine , coronavirus , disease , covid-19 , immunology , immune system , respiratory system , pathology , infectious disease (medical specialty)
Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and Coronavirus Disease 2019 (COVID-19) are caused by three distinct coronaviruses belonging to the same genus. COVID-19 and its two predecessors share many important features in their clinical presentations, and in their propensity for progression to severe disease which is marked by high rates of morbidity and mortality. However, comparison of the three viral illnesses also reveals a number of specific differences in clinical manifestations and complications, which suggest variability in the disease process. This narrative review delineates the pulmonary, cardiac, renal, gastrointestinal, hepatic, neurological and hematologic complications associated with these three respiratory coronaviruses. It further describes the mechanisms of immune hyperactivation—particularly cytokine release syndrome—implicated in the multi-organ system injury seen in severe cases of MERS, SARS and COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom